Unilateral Cochlear Implants for Severe, Profound, or Moderate Sloping to Profound Bilateral Sensorineural Hearing Loss: A Systematic Review and Consensus Statements.


Journal

JAMA otolaryngology-- head & neck surgery
ISSN: 2168-619X
Titre abrégé: JAMA Otolaryngol Head Neck Surg
Pays: United States
ID NLM: 101589542

Informations de publication

Date de publication:
01 10 2020
Historique:
pubmed: 29 8 2020
medline: 1 6 2021
entrez: 29 8 2020
Statut: ppublish

Résumé

Cochlear implants are a treatment option for individuals with severe, profound, or moderate sloping to profound bilateral sensorineural hearing loss (SNHL) who receive little or no benefit from hearing aids; however, cochlear implantation in adults is still not routine. To develop consensus statements regarding the use of unilateral cochlear implants in adults with severe, profound, or moderate sloping to profound bilateral SNHL. This study was a modified Delphi consensus process that was informed by a systematic review of the literature and clinical expertise. Searches were conducted in the following databases: (1) MEDLINE In-Process & Other Non-Indexed Citations and Ovid MEDLINE, (2) Embase, and (3) the Cochrane Library. Consensus statements on cochlear implantation were developed using the evidence identified. This consensus process was relevant for the use of unilateral cochlear implantation in adults with severe, profound, or moderate sloping to profound bilateral SNHL. The literature searches were conducted on July 18, 2018, and the 3-step Delphi consensus method took place over the subsequent 9-month period up to March 30, 2019. A Delphi consensus panel of 30 international specialists voted on consensus statements about cochlear implantation, informed by an SR of the literature and clinical expertise. This vote resulted in 20 evidence-based consensus statements that are in line with clinical experience. A modified 3-step Delphi consensus method was used to vote on and refine the consensus statements. This method consisted of 2 rounds of email questionnaires and a face-to-face meeting of panel members at the final round. All consensus statements were reviewed, discussed, and finalized at the face-to-face meeting. In total, 6492 articles were identified in the searches of the electronic databases. After removal of duplicate articles, 74 articles fulfilled all of the inclusion criteria and were used to create the 20 evidence-based consensus statements. These 20 consensus statements on the use of unilateral cochlear implantation in adults with SNHL were relevant to the following 7 key areas of interest: level of awareness of cochlear implantation (1 consensus statement); best practice clinical pathway from diagnosis to surgery (3 consensus statements); best practice guidelines for surgery (2 consensus statements); clinical effectiveness of cochlear implantation (4 consensus statements); factors associated with postimplantation outcomes (4 consensus statements); association between hearing loss and depression, cognition, and dementia (5 consensus statements); and cost implications of cochlear implantation (1 consensus statement). These consensus statements represent the first step toward the development of international guidelines on best practices for cochlear implantation in adults with SNHL. Further research to develop consensus statements for unilateral cochlear implantation in children, bilateral cochlear implantation, combined electric-acoustic stimulation, unilateral cochlear implantation for single-sided deafness, and asymmetrical hearing loss in children and adults may be beneficial for optimizing hearing and quality of life for these patients.

Identifiants

pubmed: 32857157
pii: 2769941
doi: 10.1001/jamaoto.2020.0998
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

942-953

Auteurs

Craig A Buchman (CA)

Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine in St Louis, St Louis, Missouri.

René H Gifford (RH)

Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.

David S Haynes (DS)

Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.

Thomas Lenarz (T)

Department of Otorhinolaryngology, Hannover Medical School, Hannover, Germany.

Gerard O'Donoghue (G)

Department of Otology and Neurotology, University of Nottingham, Nottingham, United Kingdom.
Nottingham Biomedical Research Center, Nottingham University Hospitals National Health Service (NHS) Trust, Nottingham, United Kingdom.

Oliver Adunka (O)

Ohio State University Wexner Medical Center, The Ohio State University, Columbus.

Allison Biever (A)

Rocky Mountain Ear Center, Englewood, Colorado.

Robert J Briggs (RJ)

Department of Otolaryngology, The University of Melbourne, Melbourne, Victoria, Australia.
Otology and Cochlear Implant Clinic, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.
Department of Surgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Matthew L Carlson (ML)

Department of Otorhinolaryngology, Mayo Clinic School of Medicine, Rochester, Minnesota.

Pu Dai (P)

Department of Otolaryngology, General Hospital of People's Liberation Army, Beijing, China.

Colin L Driscoll (CL)

Department of Otorhinolaryngology, Mayo Clinic School of Medicine, Rochester, Minnesota.

Howard W Francis (HW)

Division of Head and Neck Surgery and Communication Sciences, Duke Surgery, Duke University School of Medicine, Durham, North Carolina.

Bruce J Gantz (BJ)

Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City.

Richard K Gurgel (RK)

Division of Otolaryngology-Head & Neck Surgery, School of Medicine, University of Utah Hospital, Salt Lake City.

Marlan R Hansen (MR)

Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City.

Meredith Holcomb (M)

Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.
now with Department of Otolaryngology, University of Miami, Miami, Florida.

Eva Karltorp (E)

Cochlear Implant Department, Karolinska University Hospital, Stockholm, Sweden.

Milind Kirtane (M)

Department of ENT and Head Neck Surgery, Seth Gordhandas Sunderdas Medical College, King Edward Memorial Hospital, Mumbai, India.

Jannine Larky (J)

Cochlear Implant Center, Stanford University School of Medicine, Stanford, California.

Emmanuel A M Mylanus (EAM)

Department of Ear Nose Throat, Radboud University Medical Centre, Nijmegen, the Netherlands.

J Thomas Roland (JT)

NYU Langone Health, New York University School of Medicine, New York.

Shakeel R Saeed (SR)

Royal National Throat, Nose and Ear Hospital and University College London Ear Institute, London, United Kingdom.

Henryk Skarzynski (H)

Institute of Physiology and Pathology of Hearing, World Hearing Center, Kajetany, Nadarzyn, Poland.

Piotr H Skarzynski (PH)

Institute of Physiology and Pathology of Hearing, World Hearing Center, Kajetany, Nadarzyn, Poland.
Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland.
Institute of Sensory Organs, Kajetany, Nadarzyn, Poland.

Mark Syms (M)

Arizona Hearing Center, Phoenix.

Holly Teagle (H)

School of Population Health-Audiology, The University of Auckland, Auckland, New Zealand.

Paul H Van de Heyning (PH)

Department NKO & Head-Neck Surgery, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.

Christophe Vincent (C)

Service d'Otologie et Oto-Neurologie, Centre Hospitalier Universitaire de Lille, Lille, France.

Hao Wu (H)

Department of Otolaryngology-Head and Neck Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Tatsuya Yamasoba (T)

Department of Otorhinolaryngology and Auditory and Voice Surgery, University of Tokyo Hospital, Tokyo, Japan.

Terry Zwolan (T)

Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH